Position in LQDA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,019,200
+$312,115 QoQ
Shares Held
80,000
+1.9% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 20.4875.ToString("F0")%
Shared 0.ToString("F0")%
None 79.5125.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. LQDA ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,229,009 | $145,281,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
122,486 | $72,631,748 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
303,820 | $40,025,246 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,268,203 | $30,348,097 | |
| 5 | VTRS |
Viatris Inc
|
1,941,082 | $26,224,017 | |
| 6 | ALKS |
Alkermes plc.
|
449,531 | $15,895,416 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
194,563 | $14,757,603 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
643,856 | $13,366,450 |
All Filings in LQDA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,019,200 | 80,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,707,085 | 78,489 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,077,117 | 91,342 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,142,444 | 91,689 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,260,579 | 85,463 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $948,467 | 80,652 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $779,110 | 77,911 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $961,968 | 80,164 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,051,571 | 71,293 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $846,081 | 70,331 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $449,582 | 70,912 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $560,199 | 71,363 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $469,423 | 67,934 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $403,552 | 63,352 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $349,634 | 64,271 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $261,770 | 60,039 | Shares | Sole | 2022-08-11 | |
| 2021-03-31 | $58,130 | 21,610 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $63,454 | 21,510 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $92,102 | 18,720 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $171,515 | 20,370 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $63,613 | 13,506 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||